MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience-Reference-Cited by-同舟云学术

MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience

Published:2023-09-01 Issue:9 Volume:25 Page:643-651
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Rachmiel Marianna¹²^ORCID,Lebenthal Yael²³^ORCID,Mazor-Aronovitch Kineret²⁴⁵^ORCID,Brener Avivit²³^ORCID,Levek Noah⁴⁵^ORCID,Jacobi-Polishook Talia¹,Ben Ari Tal²⁶,Abiri Shirli²⁶,Landau Zohar⁴⁷^ORCID,Pinhas-Hamiel Orit²⁴⁵^ORCID

Affiliation:

1. Pediatric Endocrinology Unit, Shamir (Assaf Harofeh) Medical Center, Beer Yaakov, Israel.

2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

3. Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

4. National Juvenile Diabetes Center, Maccabi Health Care Services, Ra'anana, Israel.

5. Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Ramat-Gan, Israel.

6. Pediatric Endocrine and Diabetes Unit, E. Wolfson Medical Center, Holon, Israel.

7. Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0081

Reference23 articles.

1. Socio-cognitive determinants affecting insulin adherence/non-adherence in late adolescents and young adults with type 1 diabetes: a systematic review protocol

2. MiniMedTM780G Insulin Pump System with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy

3. Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users

4. Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes

5. Transitioning of People With Type 1 Diabetes From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to MiniMed 780G Advanced Hybrid Closed-Loop System: A Two-Center, Randomized, Controlled Study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained 3-Year Improvement of Glucose Control With Hybrid Closed Loop in Children With Type 1 Diabetes While Going Through Puberty;Diabetes Care;2024-07-10

2. Actualisation de la prise de position des experts français sur l’insulinothérapie automatisée en boucle fermée;Médecine des Maladies Métaboliques;2024-06

3. Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Trial;Diabetes Technology & Therapeutics;2024-05-31

4. An “out of the box” approach for prevention of ketoacidosis in youth with poorly controlled type 1 diabetes: combined use of insulin pump and long-acting insulin;Acta Diabetologica;2024-05-18

5. Real-World Evidence of Automated Insulin Delivery System Use;Diabetes Technology & Therapeutics;2024-03-01